Home » Topics » Regulatory

Regulatory
RSS

Orion receives EU approval to market Parkinson's disease treatment

Sep. 21, 1998

Early 1999 launch dates anticipated for EchoGen in European markets

Sep. 18, 1998

Novel use for a known antidepressant: doxepin relieves pruritus in patients with eczema

Sep. 18, 1998

Nasal calcitonin reduces spinal fractures in postmenopausal women with osteoporosis

Sep. 17, 1998

FDA clears diagnostic for DVT - a potentially life-threatening disorder

Sep. 16, 1998

Pylorid-containing triple therapy effective in eradicating H. pylori

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

FDA approves, HMR begins shipping new treatment for adult rheumatoid arthritis

Sep. 14, 1998

Glaxo Wellcome receives first marketing approval for new asthma therapeutic

Sep. 14, 1998

CHF treatment now available in the U.K.

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...